Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methyldopa 60mg/5ml oral liquid
0205020H0AAAKAK
|
Methyldopa | Methyldopa | Cardiovascular System | No data available |
|
Metolazone 1.25mg/5ml oral liquid
0202010V0AAAMAM
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metolazone 1mg/5ml oral liquid
0202010V0AAAFAF
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metolazone 500micrograms/5ml oral liquid
0202010V0AAAJAJ
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metolazone 5mg/5ml oral liquid
0202010V0AAAHAH
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metoprolol 100mg / Hydrochlorothiazide 12.5mg tablets
0204000W0AAAAAA
|
Generic tablet | Metoprolol tartrate with diuretic | Cardiovascular System | No data available |
|
Metoprolol 100mg/5ml oral solution
0204000K0AAAQAQ
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 10mg/5ml oral liquid
0204000K0AAAMAM
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 125mg/5ml oral solution
0204000K0AAAWAW
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 15mg/5ml oral solution
0204000K0AAAYAY
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 16mg/5ml oral solution
0204000K0AABFBF
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 17mg/5ml oral solution
0204000K0AABJBJ
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 2.5mg/5ml oral solution
0204000K0AAAPAP
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 200mg MR / Hydrochlorothiazide 25mg tab
0204000W0AAABAB
|
Generic tablet | Metoprolol tartrate with diuretic | Cardiovascular System | No data available |
|
Metoprolol 20mg/5ml oral liquid
0204000K0AAAZAZ
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 25mg/5ml oral liquid
0204000K0AAASAS
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 3.33mg/5ml oral solution
0204000K0AABABA
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 30mg/5ml oral solution
0204000K0AABHBH
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 31.25mg/5ml oral solution
0204000K0AABIBI
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 40mg/5ml oral solution
0204000K0AAARAR
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 5mg/5ml oral liquid
0204000K0AAANAN
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 6.25mg/5ml oral solution
0204000K0AABBBB
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 62.5mg/5ml oral solution
0204000K0AABCBC
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 8mg/5ml oral solution
0204000K0AABGBG
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Mexiletine 10mg/5ml oral solution
0203020P0AAAFAF
|
Mexiletine hydrochloride | Mexiletine hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.